{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:52:20Z","timestamp":1788990740165,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:00:00Z","timestamp":1559174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.critrevonc.2019.05.012","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T10:44:32Z","timestamp":1558781072000},"page":"67-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives"],"prefix":"10.1016","volume":"140","author":[{"given":"Stefania","family":"Gori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Barberis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela","family":"Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiamma","family":"Buttitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Capoluongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cortesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Genuardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Incorvaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicla","family":"La Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Normanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Pensabene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Pignata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Radice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Ricevuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sapino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierosandro","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Trevisiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Truini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Varesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4370-2008","authenticated-orcid":false,"given":"Antonio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2019.05.012_bib0005","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer a report from the Australian Ovarian Cancer study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J ClinOncol"},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0010","series-title":"Determina AIFA n.251\/2015; GU n.72 Del 27-3-2015","author":"Anon","year":"2015"},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0015","series-title":"Determina AIFA N 1367\/2018; GU n.219 Del 20-9-2018","author":"Anon","year":"2018"},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0020","unstructured":"Anon. (2019a) http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/003726\/human_med_001831.jsp&mid=WC0b01ac058001d124."},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0025","unstructured":"Anon. (2019b) https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/rubraca."},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0030","unstructured":"Anon. (2019c) http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/004249\/human_med_002192.jsp&mid=WC0b01ac058001d124."},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0035","series-title":"Linee Guida Tracciabilit\u00e0, Raccolta, Trasporto, Conservazione E Archiviazione Di Cellule E Tessuti Per Indagini Diagnostiche Di Anatomia Patologica","author":"Anon","year":"2019"},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0040","series-title":"Enigma","author":"Anon","year":"2019"},{"issue":"February","key":"10.1016\/j.critrevonc.2019.05.012_bib0045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.breast.2016.11.021","article-title":"BRCA mutation genetic testing implications in the United States","volume":"31","author":"Bayraktar","year":"2017","journal-title":"Breast."},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0050","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature."},{"issue":"June (3)","key":"10.1016\/j.critrevonc.2019.05.012_bib0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.seminoncol.2017.08.004","article-title":"Guidance statement on BRCA1\/2 tumor testing in ovarian Cancer patients","volume":"44","author":"Capoluongo","year":"2017","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ejhg.2013.125","article-title":"Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic","volume":"22","author":"Claustres","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"issue":"May","key":"10.1016\/j.critrevonc.2019.05.012_bib0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cca.2018.02.012","article-title":"A comprehensive BRCA1\/2 NGS pipeline for an immediate copy Number Variation (CNV) detection in breast and ovarian cancer molecular diagnosis","volume":"480","author":"Concolino","year":"2018","journal-title":"ClinChim Acta."},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0075","doi-asserted-by":"crossref","DOI":"10.2174\/1568009618666180308104646","article-title":"Parp inhibitors for the treatment of ovarian Cancer","author":"Cortesi","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"issue":"12","key":"10.1016\/j.critrevonc.2019.05.012_bib0080","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrc3399","article-title":"DNA repair dysregulation from cancer driver to therapeutic target","volume":"12","author":"Curtin","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0085","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1038\/onc.2013.329","article-title":"Opportunities and hurdles in the treatment of BRCA1-related breast cancer","volume":"33","author":"Drost","year":"2014","journal-title":"Oncogene"},{"issue":"March (3)","key":"10.1016\/j.critrevonc.2019.05.012_bib0090","first-page":"394","article-title":"An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice","volume":"39","author":"Ellison","year":"2018","journal-title":"HumMutat."},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0095","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1158\/1078-0432.CCR-13-0066","article-title":"Non equivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations","volume":"19","author":"George","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2017.01.020","article-title":"Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials","volume":"76","author":"George","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0105","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/jnci\/94.18.1396","article-title":"Inactivation of BRCA1 and BRCA2 in ovarian cancer","volume":"94","author":"Hilton","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0110","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1470-2045(14)70228-1","article-title":"Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomized phase 2 trial","volume":"15","author":"Ledermann","year":"2014","journal-title":"Lancet Oncol."},{"issue":"22","key":"10.1016\/j.critrevonc.2019.05.012_bib0115","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","article-title":"Niraparib maintenance therapy in Platinum-Sensitive, recurrent ovarian Cancer","volume":"375","author":"Mirza","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"November","key":"10.1016\/j.critrevonc.2019.05.012_bib0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ctrv.2016.09.009","article-title":"Trabectedin as a chemotherapy option for patients with BRCA deficiency","volume":"50","author":"Monk","year":"2016","journal-title":"Cancer Treat. Rev."},{"issue":"Supplement 8","key":"10.1016\/j.critrevonc.2019.05.012_bib0125","article-title":"Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1\/2 mutation (BRCAm): phase III SOLO1 trial","volume":"29","author":"Moore","year":"2018","journal-title":"Annals of Oncology Volume"},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0130","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2217\/fon-2016-0189","article-title":"Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients","volume":"12","author":"Pinto","year":"2016","journal-title":"Future Oncol."},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0135","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"29","author":"Plon","year":"2008","journal-title":"Hum. Mutat."},{"issue":"September (9)","key":"10.1016\/j.critrevonc.2019.05.012_bib0140","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(17)30469-2","article-title":"SOLO2\/ENGOT-Ov21 investigators. Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1\/2 mutation (SOLO2\/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"18","author":"Pujade-Lauraine","year":"2017","journal-title":"Lancet Oncol."},{"issue":"May (5)","key":"10.1016\/j.critrevonc.2019.05.012_bib0145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"February","key":"10.1016\/j.critrevonc.2019.05.012_bib0150","article-title":"Routine germline BRCA1 and BRCA2 testing in ovarian carcinoma patients: analysis of the Scottish real life experience","volume":"20","author":"Rust","year":"2018","journal-title":"BJOG."},{"issue":"October (10)","key":"10.1016\/j.critrevonc.2019.05.012_bib0155","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/1535-7163.MCT-11-0272","article-title":"BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin","volume":"10","author":"Safra","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"March (4)","key":"10.1016\/j.critrevonc.2019.05.012_bib0160","article-title":"A whole germline BRCA2 gene deletion: how to learn from CNV in silico analysis","volume":"19","author":"Scaglione","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.critrevonc.2019.05.012_bib0165","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1158\/1078-0432.CCR-07-4806","article-title":"BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark","volume":"14","author":"Soegaard","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"November","key":"10.1016\/j.critrevonc.2019.05.012_bib0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.critrevonc.2018.08.011","article-title":"The Era of PARP inhibitors in ovariancancer: \"Class Action\" or not? A systematic review and meta-analysis","volume":"131","author":"Staropoli","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2019.05.012_bib0175","series-title":"Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular genetics ACGS\/VGKL","author":"Wallis","year":"2019"},{"issue":"May (5)","key":"10.1016\/j.critrevonc.2019.05.012_bib0180","article-title":"Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer","volume":"20","author":"Wiggans","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"May","key":"10.1016\/j.critrevonc.2019.05.012_bib0185","article-title":"Multi-laboratory proficiency testing of clinical cance genomic profiling by next-generation sequencing","volume":"22","author":"Zhong","year":"2018","journal-title":"Pathol. Res. Pract."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842819301040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842819301040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:29:05Z","timestamp":1760902145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842819301040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":37,"alternative-id":["S1040842819301040"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.05.012","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}